調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

Cardiac Mapping Market by Product (Contact Mapping Systems (Electroanatomical Mapping, Basket Catheter Mapping), Non-contact Mapping Systems), Indication (Atrial Fibrillation, Atrial Flutter, AVNRT), Region - Global Forecast to 2024

世界の心臓マッピング市場：製品別（接触マッピングシステム（電気解剖学的マッピング、バスケットカテーテルマッピング）、非接触マッピングシステム）、疾患別（心房細動、心房粗動、AVNRT）、地域別

◆タイトル：Cardiac Mapping Market by Product (Contact Mapping Systems (Electroanatomical Mapping, Basket Catheter Mapping), Non-contact Mapping Systems), Indication (Atrial Fibrillation, Atrial Flutter, AVNRT), Region - Global Forecast to 2024
◆商品コード：MD 7502
◆調査・発行会社：MarketsandMarkets
◆発行日：2020年1月30日
◆ページ数：137
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD5,650 ⇒換算￥0見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥0見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥0見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

 【レポートの概要】

MarketsandMarkets社は、心臓マッピングの世界市場規模が2019年14億ドルから2024年21億ドルまで年平均8.7%成長すると予測しています。本調査レポートでは、世界の心臓マッピング市場を広く調査・分析し、市場概要、種類別（接触心臓マッピングシステム、非接触心臓マッピングシステム）分析、疾患別（心房細動、心房粗動、房室結節リエントリー頻脈（Avnrt）、その他の不整脈）分析、地域別分析、競合動向、企業概要などで取りまとめております。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の心臓マッピング市場：種類別（接触心臓マッピングシステム、非接触心臓マッピングシステム）
・世界の心臓マッピング市場：疾患別（心房細動、心房粗動、房室結節リエントリー頻脈（Avnrt）、その他の不整脈）
・世界の心臓マッピング市場：地域別
・競合動向
・企業概要

“The cardiac mapping market is projected to grow at a CAGR of 8.7% during the forecast period.”
The global cardiac mapping market size is projected to reach USD 2.1 billion by 2024 from USD 1.4 billion in 2019 at a CAGR of 8.7%. The emergence of new entrants, growing investments, funds, and grants, increasing incidences of target diseases, and growth in the geriatric population are supporting the growth of this market. However, unfavorable healthcare reforms in the US and the lack of skilled & experienced electrophysiologists may restrain the market to a certain extent during the forecast period.

“The contact cardiac mapping segment is projected to dominate the cardiac mapping products market during the forecast period.”
The cardiac mapping products market has been segmented into contact cardiac mapping systems and non-contact cardiac mapping systems. The contact cardiac mapping systems segment further includes electroanatomical mapping, basket catheter mapping, and traditional endocardial mapping. The contact cardiac mapping systems segment held the largest share of this market in 2018 and is also estimated to grow at the highest CAGR during the forecast period. Contact mapping systems are technologically more efficient and precise, hence, they provide higher accuracy, sensitivity, and efficiency in disease diagnosis and ablation.

“The atrial fibrillation applications segment held the largest market share in 2018.”
By indication, the cardiac mapping market is segmented into atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), other arrhythmias. The atrial fibrillation segment accounted for the largest share of this market in 2018. The large share of this segment can be attributed to the technological advancements in mapping systems and the rising incidences of AF and associated ablation procedures.

“The North American cardiac mapping market is expected to hold the largest share during the forecast period.”
Geographically, the cardiac mapping industry is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. North America is expected to hold the largest share of this market during the forecast period. The increase in approval rate of mapping systems and clinical trials validating cardiac mapping systems in the US, high incidence of CVDs, and growing focus of government organizations on providing funding for cardiological research are the key factors driving the North American market.

Breakdown of supply-side primary interviews:
• By Company Type: Tier 1 – 50%, Tier 2 – 30%, and Tier 3 – 20%
• By Designation: C-level – 37%, Director-level – 29%, and Others – 34%
• By Region: North America – 35%, Europe – 30%, APAC – 25%, and RoW – 10%

The major players in the cardiac mapping market include Biosense Webster (US), Abbott (US), Medtronic (Ireland), Boston Scientific Corporation (US), MicroPort Scientific Corporation (China), EP Solutions SA (Switzerland), Acutus Medical (US), Koninklijke Philips N.V. (Royal Philips) (Netherlands), Lepu Medical (China), BIOTRONIK (Germany), AngioDynamics (US), BioSig Technologies (US), APN Health (US), CoreMap (US), Kardium (Canada), Catheter Precision (US), and Epmap-System (Germany).

Research Coverage
This report studies the cardiac mapping market based on product, indication, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets concerning their growth trends and forecasts the revenue of the market segments for four main regions and respective countries.

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the cardiac mapping market, and high-growth regions with their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

【レポートの目次】

1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. – 20)
2.1 Research Data
2.2 Research Methodology Steps
2.2.1 Secondary Data
2.2.1.1 Secondary Sources
2.2.2 Primary Data
2.2.2.1 Key Insights From Primary Sources
2.2.3 Market Size Estimation Methodology
2.2.4 Revenue Mapping-Based Market Estimation
2.3 Market Data Estimation and Triangulation
2.4 Assumptions for the Study
3 Executive Summary (Page No. – 29)
4 Premium Insights (Page No. – 32)
4.1 Market Overview
4.2 Geographic Analysis: European Cardiac Mappingmarket, By Indication & Country (2019)
4.3 Market Share, By Type, 2019 vs. 2024
4.4 Market Share, By Indication, 2019 vs. 2024
4.5 Geographic Outlook: Market
5 Market Overview (Page No. – 36)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 New Entrants in the Market
5.2.1.2 Growing Investments, Funds, and Grants
5.2.1.3 Increasing Incidence of Target Diseases
5.2.1.4 Growth in the Geriatric Population
5.2.2 Restraints
5.2.2.1 Unfavorable Healthcare Reforms in the US
5.2.2.2 Lack of Skilled and Experienced Electrophysiologists
5.2.3 Opportunities
5.2.3.1 Emerging Markets
5.2.3.2 Technological Advancements
5.2.4 Challenges
5.2.4.1 Unfavorable Regulatory Scenario
5.2.4.2 Alternative Technologies
6 Cardiac Mapping Market, By Type (Page No. – 43)
6.1 Introduction
6.2 Contact Cardiac Mapping Systems
6.2.1 Electroanatomical Mapping Systems
6.2.1.1 Electroanatomical Mapping Systems Account for the Largest Share of the Contact Mapping Systems Market
6.2.2 Basket Catheter Mapping Systems
6.2.2.1 Basket Catheter Mapping Systems Provide Simultaneous, Multiple, Stable Recordings for Most Endocardial Surfaces—A Key Factor Driving Market Growth
6.2.3 Traditional Endocardial Catheter Mapping Systems
6.2.3.1 Exposure to Ionizing Radiation Due to the Need for Fluoroscopy Guidance is A Key Disadvantage of Traditional Endocardial Catheter Mapping Systems
6.3 Non-Contact Cardiac Mapping Systems
6.3.1 Non-Contact Mapping is Applicable in Cases Where the Arrhythmia Cannot Be Tolerated Or in Cases Where Clinical Arrhythmia is Not Reproducible During the Electrophysiology Study
7 Cardiac Mapping Market, By Indication (Page No. – 55)
7.1 Introduction
7.2 Atrial Fibrillation
7.2.1 Growing Number of Cases of Atrial Fibrillation and the Subsequent Increase in the Number of Ablation Procedures to Drive Market Growth
7.3 Atrial Flutter
7.3.1 High Success Rate of Radiofrequency Catheter Ablation for the Treatment of Atrial Flutter is A Major Factor Contributing to the Growth of This Market
7.4 Atrioventricular Nodal Reentry Tachycardia (Avnrt)
7.4.1 Growing Number of Avnrt Cases Across the Globe is Supporting the Growth of This Segment
7.5 Other Arrhythmias
8 Cardiac Mapping Market, By Region (Page No. – 65)
8.1 Introduction
8.2 North America
8.2.1 US
8.2.1.1 High Burden of Cvds to Drive the Demand for Cardiac Mapping in the US
8.2.2 Canada
8.2.2.1 Growing Focus of Government Organizations on Providing Research Funding to Support Market Growth in Canada
8.3 Europe
8.3.1 Germany
8.3.1.1 Favorable Healthcare Expenditure and Growing Use of Crt Devices to Drive Market Growth
8.3.2 UK
8.3.2.1 Rising Geriatric Population to Support Market Growth
8.3.3 France
8.3.3.1 Increasing Incidence of Heart Failure to Support Market Growth
8.3.4 Italy
8.3.4.1 Increasing Incidence of Cvd to Drive the Adoption of Cardiac Mapping Systems
8.3.5 Spain
8.3.5.1 Increasing Cardiac Ablation Procedures to Drive the Market in Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.1.1 Favourable Reimbursement Scenario to Support Market Growth
8.4.2 China
8.4.2.1 Growing Geriatric Population to Drive the Market for Cardiac Mapping Systems
8.4.3 India
8.4.3.1 Increasing Government Initiatives Towards Healthcare are Supporting the Growth of the Market in India
8.4.4 Rest of Asia Pacific
8.5 Rest of the World
9 Competitive Landscape (Page No. – 95)
9.1 Introduction
9.2 Market Ranking Analysis
9.3 Competitive Leadership Mapping (Overall Market)
9.3.1 Visionary Leaders
9.3.2 Innovators
9.3.3 Emerging Companies
9.3.4 Dynamic Differentiators
9.4 Competitive Scenario
9.4.1 Product Launches & Approvals
9.4.2 Partnerships, Agreements, and Collaborations
9.4.3 Acquisitions
10 Company Profile (Page No. – 103)
(Business Overview, Products Offered, Recent Developments, Competitive Analysis)*
10.1 Biosense Webster, Inc. (A Johnson & Johnson Company)
10.2 Abbott Laboratories
10.3 Medtronic Plc
10.4 Boston Scientific Corporation
10.5 Microport Scientific Corporation
10.6 EP Solutions Sa
10.7 Acutus Medical
10.8 Koninklijke Philips N.V.
10.9 Lepu Medical
10.1 Biotronik
10.11 Angiodynamics
10.12 Biosig Technologies, Inc.
10.13 APN Health, LLC
10.14 Coremap
10.15 Kardium, Inc.
10.16 Catheter Precision, Inc.
10.17 Epmap-System
*Business Overview, Products Offered, Recent Developments, Competitive Analysis Might Not Be Captured in Case of Unlisted Companies.
11 Appendix (Page No. – 129)
11.1 Discussion Guide
11.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
11.3 Available Customizations
11.4 Related Reports
11.5 Author Details

List of Tables (102 Tables)
Table 1 New Entrants in the Market
Table 2 Population Statistics, 2015 vs 2030 vs 2050 (Million Individuals)
Table 3 Market, By Type, 2017–2024 (USD Million)
Table 4 Market, By Region, 2017–2024 (USD Million)
Table 5 Contact Cardiac Mapping Market, By Type, 2017–2024 (USD Million)
Table 6 Contact Cardiac Mapping Market, By Region, 2017–2024 (USD Million)
Table 7 North America: Contact Cardiac Mapping Market, By Country, 2017–2024 (USD Million)
Table 8 Europe: Contact Cardiac Mapping Market, By Country, 2017–2024 (USD Million)
Table 9 APAC: Contact Cardiac Mapping Market, By Country, 2017–2024 (USD Million)
Table 10 Electroanatomical Mapping Systems Market, By Region, 2017–2024 (USD Million)
Table 11 North America: Electroanatomical Mapping Systems Market, By Country, 2017–2024 (USD Million)
Table 12 Europe: Electroanatomical Mapping Systems Market, By Country, 2017–2024 (USD Million)
Table 13 APAC: Electroanatomical Mapping Systems Market, By Country, 2017–2024 (USD Million)
Table 14 Basket Catheter Mapping Systems Market, By Region, 2017–2024 (USD Million)
Table 15 North America: Basket Catheter Mapping Systems Market, By Country, 2017–2024 (USD Million)
Table 16 Europe: Basket Catheter Mapping Systems Market, By Country, 2017–2024 (USD Million)
Table 17 APAC: Basket Catheter Mapping Systems Market, By Country, 2017–2024 (USD Million)
Table 18 Traditional Endocardial Mapping Systems Market, By Region, 2017–2024 (USD Million)
Table 19 North America: Traditional Endocardial Mapping Systems Market, By Country, 2017–2024 (USD Million)
Table 20 Europe: Traditional Endocardial Mapping Systems Market, By Country, 2017–2024 (USD Million)
Table 21 APAC: Traditional Endocardial Mapping Systems Market, By Country, 2017–2024 (USD Million)
Table 22 Non-Contact Cardiac Mapping Market, By Region, 2017–2024 (USD Million)
Table 23 North America: Non-Contact Cardiac Mapping Market, By Country, 2017–2024 (USD Million)
Table 24 Europe: Non-Contact Cardiac Mapping Market, By Country, 2017–2024 (USD Million)
Table 25 APAC: Non-Contact Cardiac Mapping Market, By Country, 2017–2024 (USD Million)
Table 26 Market, By Indication, 2017–2024 (USD Million)
Table 27 Market, By Region, 2017–2024 (USD Million)
Table 28 Market for Atrial Fibrillation, By Region, 2017–2024 (USD Million)
Table 29 North America: Market for Atrial Fibrillation, By Country, 2017–2024 (USD Million)
Table 30 Europe: Market for Atrial Fibrillation, By Country, 2017–2024 (USD Million)
Table 31 APAC: Market for Atrial Fibrillation, By Country, 2017–2024 (USD Million)
Table 32 Market for Atrial Flutter, By Region, 2017–2024 (USD Million)
Table 33 North America: Market for Atrial Flutter, By Country, 2017–2024 (USD Million)
Table 34 Europe: Market for Atrial Flutter, By Country, 2017–2024 (USD Million)
Table 35 APAC: Market for Atrial Flutter, By Country, 2017–2024 (USD Million)
Table 36 Market for Atrioventricular Nodal Reentry Tachycardia , By Region, 2017–2024 (USD Million)
Table 37 North America: Market for Atrioventricular Nodal Reentry Tachycardia, By Country, 2017–2024 (USD Million)
Table 38 Europe: Market for Atrioventricular Nodal Reentry Tachycardia, By Country, 2017–2024 (USD Million)
Table 39 APAC: Market for Atrioventricular Nodal Reentry Tachycardia, By Country, 2017–2024 (USD Million)
Table 40 Market for Other Arrhythmias, By Region, 2017–2024 (USD Million)
Table 41 North America: Market for Other Arrhythmias, By Country, 2017–2024 (USD Million)
Table 42 Europe: Market for Other Arrhythmias, By Country, 2017–2024 (USD Million)
Table 43 APAC: Market for Other Arrhythmias, By Country, 2017–2024 (USD Million)
Table 44 Market, By Region, 2017–2024 (USD Million)
Table 45 North America: Market, By Country, 2017–2024 (USD Million)
Table 46 North America: Market, By Type, 2017–2024 (USD Million)
Table 47 North America: Contact Market, By Type, 2017–2024 (USD Million)
Table 48 North America: Market, By Indication, 2017–2024 (USD Million)
Table 49 Clinical Trials Related to Cardiac Mapping Devices
Table 50 US: Market, By Type, 2017–2024 (USD Million)
Table 51 US: Contact Cardiac Mapping Market, By Type, 2017–2024 (USD Million)
Table 52 US: Market, By Indication, 2017–2024 (USD Million)
Table 53 Research Grants Towards Research in Cardiology
Table 54 Canada: Market, By Type, 2017–2024 (USD Million)
Table 55 Canada: Contact Cardiac Mapping Market, By Type, 2017–2024 (USD Million)
Table 56 Canada: Market, By Indication, 2017–2024 (USD Million)
Table 57 Europe: Market, By Country, 2017–2024 (USD Million)
Table 58 Europe: Market, By Type, 2017–2024 (USD Million)
Table 59 Europe: Contact Cardiac Mapping Market, By Type, 2017–2024 (USD Million)
Table 60 Europe: Market, By Indication, 2017–2024 (USD Million)
Table 61 Germany: Market, By Type, 2017–2024 (USD Million)
Table 62 Germany: Contact Cardiac Mapping Market, By Type, 2017–2024 (USD Million)
Table 63 Germany: Cardiac Mappingmarket, By Indication, 2017–2024 (USD Million)
Table 64 UK: Market, By Type, 2017–2024 (USD Million)
Table 65 UK: Contact Cardiac Mapping Market, By Type, 2017–2024 (USD Million)
Table 66 UK: ing Market, By Indication, 2017–2024 (USD Million)
Table 67 France: Market, By Type, 2017–2024 (USD Million)
Table 68 France: Contact Cardiac Mapping Market, By Type, 2017–2024 (USD Million)
Table 69 France: Market, By Indication, 2017–2024 (USD Million)
Table 70 Italy: Market, By Type, 2017–2024 (USD Million)
Table 71 Italy: Contact Cardiac Mapping Market, By Type, 2017–2024 (USD Million)
Table 72 Italy: Market, By Indication, 2017–2024 (USD Million)
Table 73 Spain: Market, By Type, 2017–2024 (USD Million)
Table 74 Spain: Contact Cardiac Mapping Market, By Type, 2017–2024 (USD Million)
Table 75 Spain: Market, By Indication, 2017–2024 (USD Million)
Table 76 Cardiac Af Ablation Procedures, By Country, 2015 vs. 2016
Table 77 RoE: Market, By Type, 2017–2024 (USD Million)
Table 78 RoE: Contact Cardiac Mapping Market, By Type, 2017–2024 (USD Million)
Table 79 RoE: Market, By Indication, 2017–2024 (USD Million)
Table 80 APAC: Market, By Country, 2017–2024 (USD Million)
Table 81 APAC: Market, By Type, 2017–2024 (USD Million)
Table 82 APAC: Contact Cardiac Mapping Market, By Type, 2017–2024 (USD Million)
Table 83 APAC: Market, By Indication, 2017–2024 (USD Million)
Table 84 Japan: Market, By Type, 2017–2024 (USD Million)
Table 85 Japan: Contact Cardiac Mappingmarket, By Type, 2017–2024 (USD Million)
Table 86 Japan: Market, By Indication, 2017–2024 (USD Million)
Table 87 China: Contact Cardiac Mappingmarket, By Type, 2017–2024 (USD Million)
Table 88 China: Contact Cardiac Mappingmarket, By Type, 2017–2024 (USD Million)
Table 89 China: Market, By Indication, 2017–2024 (USD Million)
Table 90 India: Market, By Type, 2017–2024 (USD Million)
Table 91 India: Contact Cardiac Mapping Market, By Type, 2017–2024 (USD Million)
Table 92 India: Market, By Indication, 2017–2024 (USD Million)
Table 93 RoAPAC: Market, By Type, 2017–2024 (USD Million)
Table 94 RoAPAC: Contact Cardiac Mapping Market, By Type, 2017–2024 (USD Million)
Table 95 RoAPAC: Market, By Indication, 2017–2024 (USD Million)
Table 96 RoW: Market, By Type, 2017–2024 (USD Million)
Table 97 RoW: Contact Cardiac Mapping Market, By Type, 2017–2024 (USD Million)
Table 98 RoW: Market, By Indication, 2017–2024 (USD Million)
Table 99 Right-To-Win
Table 100 Product Launches & Approvals (2017–2019)
Table 101 Agreements, Collaborations, and Partnerships (2017–2019)
Table 102 Acquisitions (2017–2019)

List of Figures (27 Figures)
Figure 1 Research Methodology: Cardiac Mapping Market
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Research Methodology: Hypothesis Building
Figure 5 Data Triangulation Methodology
Figure 6 Market Share, By Type, 2019
Figure 7 Market, By Indication, 2019 vs. 2024 (USD Million)
Figure 8 Geographical Snapshot of the Market
Figure 9 Increasing Incidence of Target Diseases and Entry of New Players to Drive the Growth of the Market
Figure 10 Atrial Fibrillation to Account for the Largest Share of the European Cardiac Mapping Market in 2019
Figure 11 Contact Cardiac Mapping to Dominate the Market During the Forecast Period
Figure 12 Atrial Fibrillation to Account for the Largest Market Share in 2019
Figure 13 APAC to Register the Highest CAGR in the Forecast Period
Figure 14 Market: Drivers, Restraints, Opportunities, & Challenges
Figure 15 Market, By Region, 2019 vs. 2024
Figure 16 North America: Market Snapshot
Figure 17 Asia Pacific: Market Snapshot
Figure 18 Key Developments in the Market, 2017–2019
Figure 19 Market Ranking Analysis, By Key Player, 2018
Figure 20 Market (Global) Competitive Leadership Mapping, 2018
Figure 21 Abbott Laboratories: Company Snapshot
Figure 22 Medtronic Plc: Company Snapshot
Figure 23 Boston Scientific Corporation: Company Snapshot
Figure 24 Microport Scientific Corporation: Company Snapshot
Figure 25 Koninklijke Philips N.V.: Company Snapshot
Figure 26 Lepu Medical: Company Snapshot
Figure 27 Angiodynamics: Company Snapshot

★調査レポート[世界の心臓マッピング市場：製品別（接触マッピングシステム（電気解剖学的マッピング、バスケットカテーテルマッピング）、非接触マッピングシステム）、疾患別（心房細動、心房粗動、AVNRT）、地域別] ( Cardiac Mapping Market by Product (Contact Mapping Systems (Electroanatomical Mapping, Basket Catheter Mapping), Non-contact Mapping Systems), Indication (Atrial Fibrillation, Atrial Flutter, AVNRT), Region - Global Forecast to 2024 / MD 7502) 販売に関する免責事項
[世界の心臓マッピング市場：製品別（接触マッピングシステム（電気解剖学的マッピング、バスケットカテーテルマッピング）、非接触マッピングシステム）、疾患別（心房細動、心房粗動、AVNRT）、地域別] ( Cardiac Mapping Market by Product (Contact Mapping Systems (Electroanatomical Mapping, Basket Catheter Mapping), Non-contact Mapping Systems), Indication (Atrial Fibrillation, Atrial Flutter, AVNRT), Region - Global Forecast to 2024 / MD 7502) についてEメールでお問い合わせ

※関連データはありません。


◆H&Iグローバルリサーチ株式会社のお客様（例）◆